Search

Showing total 370 results

Search Constraints

Start Over You searched for: Topic patients Remove constraint Topic: patients Journal alimentary pharmacology & therapeutics Remove constraint Journal: alimentary pharmacology & therapeutics
370 results

Search Results

1. Letter: 1‐kestose, the smallest fructooligosaccharide component, protection for mild to moderate ulcerative colitis patients—authors' reply.

2. Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' reply.

4. Meta-analysis: mortality in Crohn’s disease.

8. Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases – the longer the less? Authors' reply.

10. Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti‐TNF‐therapy—authors' reply.

14. Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis—are we there yet? Authors' reply.

15. Letter: screening for infectious side effects in patients with IBD—the importance and potential of real‐world remote monitoring.

19. Editorial: definition of factors associated with poor quality of life in patients with IBS—but where to from here? Authorsʼ reply.

20. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply.

21. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find.

23. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply.

24. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed.

29. Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension – authors' reply.

30. Editorial: rectal hyposensitivity in patients with hypermobile Ehlers‐Danlos syndrome and constipation—authors' reply.

33. Letter: screening for infectious side effects in patients with IBD—the importance and potential of real‐world remote monitoring. Authors' reply.

34. Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories.

35. Letter: immunotherapy in IBD patients in a SARS‐CoV‐2 endemic area.

38. Editorial: 5‐ASA in IBD patients on biologics—'stop or continue'? Authors' reply.

43. Editorial: percutaneous placement of a permanent tunnelled catheter for patients with non‐malignant ascites ‐ is it safe? Authors' reply.

44. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately—authors' reply.

45. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately.

46. Editorial: 5‐ASA in IBD patients on biologics—'stop or continue'?

47. Letter: extending FIT from DG30 to NG12 patients.

48. Letter: liver involvement and mortality in COVID‐19 patients.